Detectie van de factor-V-Leiden- en factor-II-mutaties met behulp vaneen duplex-PCR
Hele tekst
GERELATEERDE DOCUMENTEN
18 Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH High risk of thrombosis m patients homozygous for factor V Leiden 30 (activated protein C resistance) Blood 1995, 85 1504-8.
21 März W Seydewitz H, Winkelmann B, Chen M, Nauck M Witt I Mutation m coagulation factor V associated with resistance to activated protem C m patients with coronary artery
Mild hyperhomocystememia is an estabhshed nsk factor for both ar- tenosclerosis and thrombosis, and may be caused by genetic and envi- ronmental factors
While most studies have found no relationship between factor V Leiden and arterial thrombosis (9), in a recent study the mutation predicted myocardial infarction (MI) in young
Bij trombofilie, zowel door deficienties van prote'ine C, proteme S of antitrombine, als door factor V Leiden of protrombine 20210A, is dit risico 5-10 maal ver- hoogd.. Dit
[r]
Factoi VIII activity (factor VIII C) and factor VIII antigen (factor VIII Ag) levels abovelSO lU/dl are associated with a five- to sixfold increased nsk of venous thrombosis
15 years) These compansons emphasize that the estimated nsk of thrombosis for carneis of factor V Leiden depends on the mclusion critena and is much higher m selected and